201 related articles for article (PubMed ID: 32260165)
61. Twist Expression in Pleomorphic Adenoma, Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma of Salivary Glands.
Pardis S; Zare R; Jaafari-Ashkavandi Z; Ashraf MJ; Khademi B
Turk Patoloji Derg; 2016; 32(1):15-21. PubMed ID: 26832177
[TBL] [Abstract][Full Text] [Related]
62. Malignant salivary gland tumors and cyclo-oxygenase-2: a histopathological and immunohistochemical analysis with implications on histogenesis.
Akrish S; Peled M; Ben-Izhak O; Nagler RM
Oral Oncol; 2009 Dec; 45(12):1044-50. PubMed ID: 19729335
[TBL] [Abstract][Full Text] [Related]
63. Classification of the pathohistology of diseases of the salivary glands - review of 2,600 cases in the Salivary Gland Register.
Seifert G; Donath K
Beitr Pathol; 1976 Oct; 159(1):1-32. PubMed ID: 999595
[TBL] [Abstract][Full Text] [Related]
64. [Tumor microenvironment in salivary gland carcinomas: Consequences for new therapeutic concepts].
Meyer MF; Arolt C; Kansy BA; Doescher J; Quaas A; Beutner D; Lang S; Klußmann JP
HNO; 2020 Dec; 68(12):927-934. PubMed ID: 32929519
[TBL] [Abstract][Full Text] [Related]
65. 11q21 rearrangement is a frequent and highly specific genetic alteration in mucoepidermoid carcinoma.
Clauditz TS; Gontarewicz A; Wang CJ; Münscher A; Laban S; Tsourlakis MC; Knecht R; Sauter G; Wilczak W
Diagn Mol Pathol; 2012 Sep; 21(3):134-7. PubMed ID: 22847156
[TBL] [Abstract][Full Text] [Related]
66. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential.
Foschini MP; Krausz T
Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833
[TBL] [Abstract][Full Text] [Related]
67. Cathepsin-D and tumor associated antigen DF3 in salivary gland neoplasia. Differential diagnostic and prognostic applications.
Vigneswaran N; Müller S; DeRose P; Cohen C
Pathol Res Pract; 1994 Dec; 190(12):1174-84. PubMed ID: 7540754
[TBL] [Abstract][Full Text] [Related]
68. Immunohistochemical and molecular profile of salivary gland cancer in children.
Locati LD; Collini P; Imbimbo M; Barisella M; Testi A; Licitra LF; Löning T; Tiemann K; Quattrone P; Bimbatti E; Chiaravalli S; Casanova M; Tamborini E; Carta R; Gasparini P; Guzzo M; Massimino M; Ferrari A
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28139061
[TBL] [Abstract][Full Text] [Related]
69. Pembrolizumab as a first line therapy in a patient with extensive mucoepidermoid salivary gland carcinoma. A complete clinical, radiological and pathological response. A very specific case.
Farhat R; Asna N; Avraham Y; Khater A; Asakla M; Safia A; Szvalb S; Elkhatib N; Merchavy S
Discov Oncol; 2022 May; 13(1):37. PubMed ID: 35624380
[TBL] [Abstract][Full Text] [Related]
70. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
71. Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study.
Matsubayashi S; Yoshihara T
Eur Arch Otorhinolaryngol; 2007 Jul; 264(7):789-95. PubMed ID: 17310348
[TBL] [Abstract][Full Text] [Related]
72. PD-L1 expression is an unfavourable prognostic indicator in Asian renal cell carcinomas.
Yeong J; Zhao Z; Lim JCT; Li H; Thike AA; Koh VCY; Teh BT; Kanesvaran R; Toh CK; Tan PH; Khor LY
J Clin Pathol; 2020 Aug; 73(8):463-469. PubMed ID: 31980560
[TBL] [Abstract][Full Text] [Related]
73. PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours.
Alves FA; Pires FR; De Almeida OP; Lopes MA; Kowalski LP
Int J Oral Maxillofac Surg; 2004 Sep; 33(6):593-7. PubMed ID: 15308260
[TBL] [Abstract][Full Text] [Related]
74. Epithelial membrane antigen and DOG1 expression in minor salivary gland tumours.
Andrade EP; Teixeira LN; Montalli VAM; Garcia FM; Passador-Santos F; Soares AB; Araújo VC
Ann Diagn Pathol; 2019 Dec; 43():151408. PubMed ID: 31629156
[TBL] [Abstract][Full Text] [Related]
75. Clinical implication of CD166 expression in salivary gland tumor.
Andisheh-Tadbir A; Ashraf MJ; Khademi B; Ahmadi S
Tumour Biol; 2015 Apr; 36(4):2793-9. PubMed ID: 25472586
[TBL] [Abstract][Full Text] [Related]
76. S-100 protein in salivary gland tumors: an immunohistochemical study of 129 cases.
Zarbo RJ; Regezi JA; Batsakis JG
Head Neck Surg; 1986; 8(4):268-75. PubMed ID: 3017896
[TBL] [Abstract][Full Text] [Related]
77. Evaluation of PD-L1 Expression in Colorectal Carcinomas by Comparing Scoring Methods and Their Significance in Relation to Clinicopathologic Parameters.
Frančina M; Mikuš M; Mamić M; Jovanović T; Ćorić M; Lovrić B; Vukoja I; Zukanović G; Matković K; Rajc J; Slišurić F; Jurić-Marelja M; Augustin G; Tomaš I
Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786305
[TBL] [Abstract][Full Text] [Related]
78. Primary salivary gland-type lung cancer: clinicopathological analysis of 88 cases from China.
Zhu F; Liu Z; Hou Y; He D; Ge X; Bai C; Jiang L; Li S
J Thorac Oncol; 2013 Dec; 8(12):1578-84. PubMed ID: 24389442
[TBL] [Abstract][Full Text] [Related]
79. Prognostic significance of PD-L1 expression and CD8+ T cell infiltration in pulmonary neuroendocrine tumors.
Wang H; Li Z; Dong B; Sun W; Yang X; Liu R; Zhou L; Huang X; Jia L; Lin D
Diagn Pathol; 2018 May; 13(1):30. PubMed ID: 29789013
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]